OFG
ABMD

Oxford Financial Group’s Abiomed Inc ABMD Stock Holding History

Oxford Financial Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,599
Closed -$1.87M – 278
2022
Q3 		$1.87M Buy
7,599
+1,490
+24% +$402K 0.28% 36
2022
Q2 		$1.51M Buy
6,109
+4,645
+317% +$1.25M 0.22% 46
2022
Q1 		$485K Hold
1,464
– – 0.06% 119
2021
Q4 		$526K Buy
1,464
+14
+1% +$4.73K 0.06% 117
2021
Q3 		$472K Sell
1,450
-6,760
-82% -$2.29M 0.06% 118
2021
Q2 		$2.56M Hold
8,210
– – 0.34% 33
2021
Q1 		$2.62M Sell
8,210
-14
-0.2% -$4.48K 0.36% 29
2020
Q4 		$2.67M Buy
8,224
+14
+0.2% +$3.87K 0.39% 29
2020
Q3 		$2.27M Buy
+8,210
New +$2.37M 0.37% 31

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Oxford Financial Group's ABMD Position: Q4 2022 in Review

Oxford Financial Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 7,599 shares — an estimated $1.87M sold.

Oxford Financial Group first reported a position in ABMD in Q3 2020 and held it in 9 quarters. The position peaked at $2.67M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Oxford Financial Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Oxford Financial Group sold 7,599 Abiomed Inc shares in Q4 2022, an estimated $1.87M.
  • Oxford Financial Group first reported a position in Abiomed Inc in Q3 2020 and held it in 9 quarters.
  • Oxford Financial Group's Abiomed Inc position peaked at $2.67M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Oxford Financial Group's 13F filing for Q4 2022, filed 14 Feb 2023.